Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background Ambiguous or unnecessary radiologist recommendations for additional imaging (RAIs) can lead to excessive imaging use and diagnostic errors. Purpose To determine the cumulative impacts of multifaceted technology-enabled interventions aimed at optimizing RAI on RAI rate, actionability, and resolution over an 8-year period. Materials and Methods In this retrospective cohort study, conducted from January 2015 to December 2022, radiology reports from two tertiary hospitals (study site and control site) were analyzed. A series of quality improvement interventions, including radiologist education, electronic communication tools for tracking RAIs, and performance reports, were implemented at the study site but not at the control site. The RAI rate trend over time was compared between the sites using linear regression. Mixed-effects logistic regression was performed to assess the intervention impact on the RAI rate. RAI actionability and resolution were compared between the sites using the Fisher exact test. values were corrected using the Bonferroni method. Results Among 7 502 521 total radiology reports (1 323 459 patients) (study site, 3 608 977 reports and 660 051 patients; control site, 3 893 544 reports and 690 115 patients), the RAI rate of the study site decreased by 44%, from 10% (8202 of 81 586) to 5.6% (8972 of 159 599), but remained unchanged at the control site, at 10.9% (8757 of 80 030) vs 11% (16 978 of 153 711) (regression coefficient, -0.09; 95% CI: -0.1, -0.09; < .001). RAI rates declined with each successive intervention at the study site ( < .001), with regression coefficients decreasing progressively from -0.12 (95% CI: -0.14, -0.10) for the initial intervention to -0.81 (95% CI: -0.83, -0.78) for the final intervention. Recommendation actionability at the study site increased 7.6-fold (from 5.6% [19 of 340] to 42.3% [144 of 340]; < .001) but remained unchanged at the control site (from 15.0% [51 of 340] to 13.8% [47 of 340]; = .73). Actionable RAIs were more frequently resolved at the study site than at the control site (84.7% [122 of 144] vs 59.6% [28 of 47]; < .001). Conclusion Multifaceted interventions to optimize RAI improved the rate, actionability, and resolution of RAI. © RSNA, 2025 See also the editorial by Russell in this issue.

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.243750DOI Listing

Publication Analysis

Top Keywords

study site
28
control site
24
rai rate
16
site
13
actionability resolution
12
site control
12
rai
9
radiologist recommendations
8
recommendations additional
8
additional imaging
8

Similar Publications

Influence of the Metal Support─Catalyst Contact on the Performance of NiO-Based O Evolution Electrocatalysts.

ACS Appl Mater Interfaces

September 2025

Surface Science Laboratory, Department of Materials and Geosciences, Technical University of Darmstadt, Peter-Grünberg-Straße 4, 64287 Darmstadt, Germany.

The performance of NiO-based electrocatalysts for the oxygen evolution reaction (OER) is strongly influenced by the interface between the metal support (current collector) and the catalyst layer, which modulates electronic properties and electrochemical activity. This study systematically investigates the solid-solid interface behavior of NiO thin films prepared by reactive magnetron sputtering on Pt, Au, and Ni, followed by electrochemical characterization. Stepwise NiO deposition and X-ray photoelectron spectroscopy reveal distinct band alignment and electronic structure differences at the metal-catalyst interface.

View Article and Find Full Text PDF

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as Empagliflozin, are antidiabetic drugs that reduce glucose levels and have emerged as a promising therapy for patients with heart failure (HF), although the exact molecular mechanisms underlying their cardioprotective effects remain to be fully elucidated. The EmDia study, a randomized, double-blind trial conducted at the University Medical Center of Mainz, has confirmed the beneficial effects of Empagliflozin in HF patients after both one and twelve weeks of treatment. In this work, we aimed to assess whether changes in lipid profiles driven by Empagliflozin use in HF patients in the EmDia trial could assist in gaining a better understanding of its cardioprotective mechanisms.

View Article and Find Full Text PDF

Background: Stereotactic Body Radiotherapy (SBRT) has been proven to be a safe and effective alternative to surgery in patients with metastatic primary sarcoma. However, data describing tumor response in relation to the given radiotherapy dose is lacking. Therefore, this study aims at analyzing efficacy and dose-response relationship in a retrospective cohort.

View Article and Find Full Text PDF